OpenLB
Open Library of Bioscience
Advanced Search
Journal of clinical medicine
Nov 10, 2021;10 (22):

Mitochondrial Medicine in the COVID-19 Era.

Daniele Orsucci
Author Information
  1. Daniele Orsucci: Unit of Neurology, San Luca Hospital, Via Lippi-Francesconi, 55100 Lucca, Italy. ORCID
PMID: 34830516 DOI: 10.3390/jcm10225235

Abstract

Mitochondrial disorders are a remarkably complex group of diseases caused by impairment of the mitochondrial respiratory chain (or electron transport chain) [...].

Keywords

CPEO Leber Leigh syndrome MELAS MERRF MNGIE NARP PEO mitochondrial myopathy mtDNA

References

  1. J Clin Med. 2021 Apr 16;10(8): [PMID: 33923719]
  2. Mitochondrion. 2021 May;58:243-245 [PMID: 33798770]
  3. J Neurol. 2021 Nov;268(11):3988-3991 [PMID: 33796896]
  4. J Clin Med. 2021 Mar 17;10(6): [PMID: 33802970]
  5. J Neuroophthalmol. 2021 Sep 1;41(3):316-320 [PMID: 34415266]
  6. Drugs Context. 2019 Jul 04;8:212588 [PMID: 31391854]
Editorial
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0Mitochondrialmitochondrialchaindisordersremarkablycomplexgroupdiseasescausedimpairmentrespiratoryelectrontransport[]MedicineCOVID-19EraCPEOLeberLeighsyndromeMELASMERRFMNGIENARPPEOmyopathymtDNA

Similar Articles

Cited By

No available data.